<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02766231</url>
  </required_header>
  <id_info>
    <org_study_id>K-09</org_study_id>
    <nct_id>NCT02766231</nct_id>
  </id_info>
  <brief_title>Physica CR and PS Clinical Trial</brief_title>
  <official_title>A Multicentre, Prospective Study Evaluating Clinical, Radiographic and Patient-reported Outcomes of Total Knee Arthroplasty With Physica CR or Physica PS Prosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Limacorporate S.p.a</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Limacorporate S.p.a</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type &amp; Design:

      Post-market, international, multicentre Prospective, parallel groups, open-label, baseline
      controlled

      Objectives:

        1. Assessment of clinical, radiographic and patient-reported outcomes of Physica CR and PS
           designs

        2. Incidence of adverse events and identification of possible risk factors for
           unsatisfactory results

        3. Mid-term survivorship of the implants
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical change in Knee Society Score (KSS)</measure>
    <time_frame>from preoperative (baseline) to 5 years after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical change in Knee Society Score (KSS)</measure>
    <time_frame>preoperatively (baseline), 3 months, 6 months, 1 year, 2 years, 3 years after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional change in Timed up and Go (TUG) test</measure>
    <time_frame>preoperatively (baseline), 3 months, 6 months, 1 year, 2 years, 3 years and 5 years after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Knee injury and Osteoarthritis Outcome Score (KOOS)</measure>
    <time_frame>preoperatively (baseline), 3 months, 6 months, 1 year, 2 years, 3 years and 5 years after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Satisfaction Visual Analogue Scale (Satisfaction VAS)</measure>
    <time_frame>3 months (baseline), 6 months, 1 year, 2 years, 3 years, 4 years and 5 years after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Forgotten Joint Score (FJS-12)</measure>
    <time_frame>3 months (baseline), 6 months, 1 year, 2 years, 3 years, 4 years and 5 years after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thickness and location of symptomatic radiolucent lines</measure>
    <time_frame>0 months (baseline), 3 months, 6 months, 1 year, 2 years, 3 years and 5 years after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival rate (Kaplan-Meier)</measure>
    <time_frame>3 years and 5 years after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of device-related AE/SAE</measure>
    <time_frame>0 months, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years and 5 years after surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Physica CR</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Physica PS</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Physica CR</intervention_name>
    <description>Cruciate tretaining total knee replacement</description>
    <arm_group_label>Physica CR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Physica PS</intervention_name>
    <description>Posterior Stabilized total knee replacement</description>
    <arm_group_label>Physica PS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        General population of subjects requiring a primary TKR with a diagnosis of painful primary
        or secondary osteoartrithis not responding to other conservative treatments, after the
        review of medical history and the radiographic evaluation of the affected knee.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and females

          2. Age 22-78 years

          3. Any race

          4. Ambulatory patients

          5. Patients who have a medical condition with over 5 years of life expectancy

          6. Patients with painful primary knee osteoarthritis

          7. Patients with painful secondary knee osteoarthritis

          8. Patients who have undamaged and functional collateral and posterior cruciate ligaments
             for the group requiring Physica CR

          9. Patients who have undamaged and functional collateral ligaments for the group
             requiring Physica PS

         10. Patients with flexion ≥90° on the affected side

         11. Patients with a fixed flexion contracture &lt;20°

         12. Patients with previous metaphyseal tibial or femoral osteotomy performed more than 5
             years before the screening visit, in case of plate removal surgery it is done not
             early than 1 year

         13. Patients who understand the conditions of the study and are willing and able to comply
             with the prescribed rehabilitation and to perform all scheduled follow-up visits

         14. Patients who have signed the Ethics Committee approved study-specific Informed Consent
             Form prior to the surgery

        Exclusion Criteria:

          1. Patients with BMI above 35 kg/m2 (severe obesity)

          2. Previous partial knee replacement or patellofemoral joint replacement and previous
             patellectomy

          3. Primary Total Knee Replacement (TKR) in the affected knee

          4. Varus deformity &gt;20° or Valgus deformity &gt;15°

          5. Patients with a fixed flexion contracture &gt;20°

          6. Previous intra-articular fractures of the affected knee

          7. Previous knee replacement on the contralateral side within the last year and whose
             outcome is achieving an KSS&lt; 60 points

          8. Patients with symptomatic Osteoarthritis (OA) of the spine if the assessment of pain
             with Numeric Rating Scale is &gt;4

          9. Patients with an history of infections (on the affected knee or systemic)

         10. Muscular insufficiency or absence of muscoligamentous supporting structures required
             for adequate soft tissue balance

         11. Patients who have damaged or absence of the posterior cruciate ligament for the group
             requiring Physica CR

         12. Patients with known or suspicious metal hypersensitivity

         13. Recurrent medical history of severe allergic or immune-mediated reactions

         14. Vascular insufficiency of lower limbs severe enough to interfere

         15. Current treatment or treatment within the previous 2 years before the screening visit
             for malignant and life-threatening non-malignant disorders

         16. Any clinically significant pathology based on clinical history that the Investigator
             feels may affect the study evaluation including:

               -  any intercurrent chronic disease or condition that may interfere with the
                  completion of the 5-year follow-up, such as liver disease, severe coronary
                  disease, drug or alcohol abuse

               -  significant neurological or musculoskeletal disorders or disease that may
                  adversely affect gait and compromise functional recovery

               -  neuromuscular or neurosensory deficit which would limit the ability to assess the
                  performance of the device

               -  known metabolic disorders leading to progressive bone deterioration

         17. Patients who have known co-existent medical condition with less 5 years of life
             expectancy

         18. Previous organ transplant surgery

         19. Any psychiatric illness that would prevent comprehension of the details and nature of
             the study

         20. Participation in any experimental drug/device study within the 6 months prior to the
             screening visit

         21. Female patients who are pregnant, nursing, or planning a pregnancy -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe Peretti</last_name>
    <role>Principal Investigator</role>
    <affiliation>I.R.C.C.S. Galeazzi_ Milano</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giuseppe Peretti</last_name>
    <email>giuseppe.peretti@unimi.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>I.R.C.C.S. Galeazzi</name>
      <address>
        <city>Milano</city>
        <zip>20161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Peretti</last_name>
      <email>giuseppe.peretti@unimi.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2016</study_first_submitted>
  <study_first_submitted_qc>May 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2016</study_first_posted>
  <last_update_submitted>May 5, 2016</last_update_submitted>
  <last_update_submitted_qc>May 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

